Previous Article | Next Article 
Infect Immun, August 1998, p. 3783-3787, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Only Viable Parasites Are Detected by PCR following
Clearance of Rodent Malarial Infections by Drug Treatment or
Immune Responses
William
Jarra1 and
Georges
Snounou2 *
Division of Parasitology, National Institute
for Medical Research, The Ridgeway, Mill Hill, London NW7
1AA,1 and
Department of Infection and
Tropical Medicine, Imperial College School of Medicine, Lister
Unit, Northwick Park Hospital, Harrow, Middlesex HA1
3UJ,2 United Kingdom
Received 3 March 1998/Returned for modification 24 April
1998/Accepted 11 May 1998
 |
ABSTRACT |
Detection and analysis of pathogens by PCR plays an important role
in infectious disease research. The value of these studies would be
diminished if nuclear material from dead parasites were found to remain
in circulation for extended periods and thus result in positive
amplification. This possibility was tested in experimental rodent
malaria infections. Blood samples were obtained from infected mice
during and following drug or immune clearance of Plasmodium chabaudi chabaudi parasitemias. Detection of parasite DNA by a sensitive Plasmodium-specific PCR amplification assay was
associated with the presence of viable parasites, as detected by
subinoculation. No parasite DNA could be detected by PCR 48 h
after the injection of killed parasites into mice. Nuclear material
from parasites removed by drug or immune responses is rapidly cleared
from the circulation and does not contribute significantly to
amplification. Thus, results from PCR analysis of malaria-infected
blood accurately reflect the presence of live parasites.
 |
INTRODUCTION |
Detection and analysis of
Plasmodium parasites by PCR are done in numerous
investigations. PCR assays are more sensitive than microscopy and are
therefore often used to detect the parasite and identify the species
(3, 17, 18, 29, 32, 33). The specificity of PCR has also
been exploited for the analysis of parasite populations. Investigations
of the diversity of Plasmodium falciparum from fresh field
isolates have been greatly improved by the analysis of polymorphic
genetic markers through PCR (7, 13, 25, 34, 36). DNA
amplification is thus becoming an important tool for the study of
malaria parasites. This technique is also being increasingly applied to
other parasitic diseases, as well as bacterial and viral infections. As
a result of this high sensitivity, DNA amplification is often observed
in the absence of microscopically demonstrable parasites. Concern has
therefore been expressed that, in some cases, the target of PCR
amplification might be circulating DNA derived from dead parasites or
from parasites ingested by peripheral phagocytic cells. To resolve this
issue, one must investigate whether positive amplification can be
obtained in the absence of viable parasites.
This issue was addressed experimentally with mice by using P. chabaudi chabaudi. The efficiency of clearance of nonviable parasites was ascertained in three distinct experiments. In a first
instance, parasites killed by freeze-thawing were injected directly
into the bloodstream. The two other sets of experiments are
representative of parasite clearance under natural conditions: (i)
elimination of parasites by drug treatment and (ii) resolution of
parasitemia by immune mechanisms. Throughout the experiments, blood was
collected daily and each sample was divided equally, with one aliquot
used for PCR analysis and the other subinoculated into reporter mice to
test for the presence of viable parasites. The sensitivity of a
previously described PCR detection assay, in which conserved sequences
of the small-subunit rRNA (ssrRNA) gene are targeted (14),
was improved by the addition of a nested reaction. We have found that
positive amplification was associated with the presence of viable
parasites as detected by subinoculation.
 |
MATERIALS AND METHODS |
Mice.
CBA/Ca male mice 3 to 4 months old and weighing 24 to
26 g at the time of primary infection were used throughout the
study. Infectivity tests were done by using outbred Parkes' male
(reporter) mice. All mice were obtained, housed, and used as previously
described (16).
Parasites.
P. c. chabaudi AS-parasitized erythrocytes
(PE), prepared as previously described (16), were used to
initiate primary infections in normal mice, to reinfect immune mice in
order to produce hyperimmune animals, and to challenge these or normal
mice so as to provide samples for DNA analysis. Unless otherwise
stated, all infections were initiated by the intraperitoneal (i.p.)
route using defined numbers of PE.
Blood collection and analysis.
Thin tail blood smears were
collected daily, methanol fixed, and Giemsa stained. Parasites were
enumerated by microscopic examination, and the data was presented as
log parasitemia for individual experimental mice or, where appropriate,
as log geometric mean parasitemia for groups of animals. The raw data
was transformed and evaluated as previously described (16).
Blood samples for subinoculation and PCR analysis were also collected
from individual mice immediately before clearance of parasites was
initiated and on a regular basis thereafter until the experiment was
terminated. For each sample, 20 µl of blood was taken from individual
mice from the tip of the tail and mixed into 400 µl of Krebs
saline-glucose-heparin (5). All of the experiments were
repeated at least twice, and similar results were obtained.
Infectivity testing.
A 200-µl volume of each sample
obtained as described above was then immediately injected i.p. into a
reporter mouse. We have established by using serial dilution of
parasites in whole blood, that patent infections are consistently
observed following inoculation with very few (1 to 10) PE. Infections
in reporter mice were assessed by microscopy (Giemsa-stained tail blood
smears) for 14 days after the inoculation before being considered
negative.
PCR template preparation.
Parasites in the remaining 200 µl were released by addition of 1 µl of saponin (10%, wt/vol) and
concentrated by centrifugation (8,000 × g for 5 min).
The supernatant was discarded, and the parasite pellet was stored at
60°C before template preparation. DNA was prepared by resuspending
the pellet in lysis buffer (10 mM Tris-HCl [pH 8.0], 20 mM EDTA [pH
8.0], 0.5% sodium dodecyl sulfate, 2.0 mg of pronase E per ml). The
DNA was purified by phenol extraction followed by ethanol precipitation
(24) and resuspended in 10 µl of water. Mouse genomic DNA
was used as negative controls.
PCR analysis.
Amplification was carried out in a total
volume of 20 µl containing, in all cases, 50 mM KCl, 10 mM Tris-HCl
(pH 8.3), 0.1 mg of gelatin per ml, 2 mM MgCl2, 125 µM
(each) deoxynucleoside triphosphate, and 0.4 U of AmpliTaq polymerase.
In the first amplification reaction of the nested PCR protocol, 5 µl
of the DNA template prepared as described above was used to initiate
the amplification with 250 nM (each) rPLU1 (5'-TCA AAG ATT AAG CCA TGC
AAG TGA) and rPLU2 (5'-ATC TAA GAA TTT CAC CTC TGA CAT CTG). In the
second reaction, 1 µl of the product from the first reaction was used to initiate amplification with a 250 nM concentration of each of the
previously described primers (14) rPLU3 (5'-TTT TTA TAA GGA
TAA CTA CGG AAA AGC TGT) and rPLU4 (5'-TAC CCG TCA TAG CCA TGT TAG GCC
AAT ACC). The cycling parameters were as follows. Reaction mixtures
were heated to 95°C for 5 min prior to cycling at 62°C (first
reaction) or at 64°C (second reaction) for 2 min of annealing, 72°C
for 2 min of extension, and 94°C for 1 min of denaturation. We
carried out 25 cycles for the first reaction and 30 for the second. The
amplification cycles were completed by one further annealing step,
followed by a 5-min extension step, and the product was stored at 4°C
and analyzed as described in the figure legend.
Clearance experiments. (i) Injection of freeze-thawed
material.
The parasites were obtained by total exsanguination of
an infected mouse. After removal of the plasma, the erythrocytes were then frozen as a thin shell of material in a round-bottom flask in a
dry ice-methanol bath (
65°C) and kept at this temperature for 2 min
before being rapidly thawed at 37°C for 2 min. This freeze-thaw cycle
was repeated four times. An aliquot of this material was removed and
used as a positive PCR control, and the remainder was equally divided
and injected intravenously into two recipient mice. Each mouse received
9.5 × 108 freeze-thawed PE.
(ii) Drug treatment.
Infections were initiated with 5 × 104 P. c. chabaudi AS PE in a group of five
mice. On day 10 postinfection, the mice were injected i.p. with
pyrimethamine (Sigma) at 30 mg/kg of body weight daily up to and
including day 16.
(iii) Immune clearance.
Five mice with homologous immunity
to P. c. chabaudi AS were obtained as follows. Following
clearance of a primary infection initiated by inoculation with 5 × 104 PE, three further inoculations of PE (3 × 108, 4 × 108, and 1 × 109, respectively) were performed on days 128, 149, and
160. In all cases, parasites from these booster infections were cleared
within 6, 5, and 3 days, respectively. On day 225, blood samples were removed from two of these mice for PCR-subinoculation analysis in order
to confirm that no parasites were present in the circulation before a
challenge inoculation with 6 × 108 PE.
 |
RESULTS |
Specificity and sensitivity of the PCR assay.
The detection of
parasites was achieved by PCR amplification using oligonucleotide
primers which hybridize to sequences conserved in the ssrRNA genes of
all Plasmodium organisms. A nested PCR approach was used to
enhance the sensitivity of the assay. Amplification of a fragment of
approximately 230 bp was obtained for all of the parasite species
tested, and no PCR product could be detected when human or mouse DNA
was present alone. The parasites tested included all of the species
infecting humans (P. falciparum, P. vivax,
P. malariae, and P. ovale) and all of the species
and subspecies infecting rodents (P. c. chabaudi, P. c. adami, P. berghei, P. vinckei vinckei,
P. v. lentum, P. v. petteri, P. yoelii
yoelii, P. y. nigeriensis, and P. y.
killicki). The sensitivity of detection was close to the maximum
theoretical value of 1 parasite per sample, as determined by
amplification of purified DNA from serial dilutions of known quantities
of viable P. c. chabaudi AS parasites in whole blood.
Ten-microliter blood samples expected to contain one PE consistently
gave positive amplification. The intensity of the amplified fragment
was, as expected in nested PCR amplification, the same with as
few as 1 parasite to 10,000 parasites present in the reaction mixture
but faded rapidly at lower parasite contents (there are less than 10 ssrRNA genes per genome).
Parasite clearance. (i) Injection of freeze-thawed parasites.
In a first experiment, freeze-thawed P. c. chabaudi AS
parasites were injected into two normal mice in order to determine the
rate of clearance of DNA derived from dead parasites. The mice were
sampled for PCR analysis immediately before and after the injection and
daily for the next 13 days. Subinoculations were performed on day 1 and
then on alternate days. The freeze-thawed material injected did not
contain any viable parasites, as demonstrated by the fact that patent
parasitemia could not be detected in any of the reporter mice injected
with the daily samples. Moreover, on day 14, the experimental animals
were sacrificed and exsanguinated, and all of the blood from each mouse
was equally divided and injected i.p. into two reporter mice which also
remained negative. The PCR assay proved positive for the sample taken
immediately following the injection of the freeze-thawed material and
that taken 24 h later. Specific amplification of
Plasmodium DNA from any later sample was not observed (Fig.
1A).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Following the addition of 5 µl of loading buffer, 15 µl of the PCR product was electrophoresed on a 3% MetaPhor agarose
gel (Flowgen Instruments Ltd.) in TBE buffer (100 mM Tris-HCl, 100 mM
boric acid, 5 mM EDTA) and visualized by UV transillumination after
ethidium bromide staining. Molecular weight markers (lanes M) are a
100-bp ladder; the size of the lowest band visible is 100 bp. Results
(+ or ) of subinoculations are given for reporter mice below each
gel. The gels and the subinoculation results are aligned under the
corresponding day when the sample analyzed was collected. (A) PCR and
subinoculation analyses of blood samples obtained after injection of
freeze-thawed P. c. chabaudi AS parasites into a
representative mouse. The sample taken from the mouse before injection
of parasite material is designated B, and the one taken
immediately after is A. Values above the gel are the numbers
of days following the injection of parasite material. (B) Parasitemia
curve and PCR-subinoculation analyses of a representative mouse in
which the parasitemia was cleared by pyrimethamine treatment (initiated
on day 10, as indicated by the arrow designated T). (C) Parasitemia
curve and PCR-subinoculation analyses of parasite clearance in a
representative hyperimmune mouse. The challenge inoculum was
administered immediately after collection of sample B. E,
erythrocytes.
|
|
(ii) Drug treatment.
In another experiment, the presence of
parasite DNA in the circulation following the elimination of parasites
by drug treatment was determined. Samples for subinoculation testing
were obtained from two mice following drug treatment and after the
parasites could not be detected microscopically (days 13 to 19 inclusive). Viable parasites were detected by subinoculation on day 13 in only one mouse. In only one of the other reporter mice, a single parasite was seen 7 days after the subinoculation with the blood samples collected on day 15. This reporter mouse, however, remained negative throughout the duration of the experiment. This observation was not repeated for any of the reporter mice from the duplicate experiment. PCR analysis was performed on samples collected from day 11 to day 19 inclusive and proved negative for day +17 on. The PCR product
obtained from the day 14 to 16 samples was of very low intensity and
might not be reproduced faithfully in Fig. 1B.
(iii) Immune clearance.
In a final experiment, the possibility
that parasite DNA remained in the peripheral blood after removal of
parasites by immune mechanisms was ascertained by injecting 6 × 108 viable parasites into two hyperimmune mice. These mice
were then sampled for subinoculation and PCR analysis for the next 13 days. Patent parasitemia was only observed in reporter mice inoculated with blood taken on days 1 to 3. PCR amplification was also only observed for samples taken on days 1 to 3 (Fig. 1C).
 |
DISCUSSION |
Malaria infections are chronic and often can last for many months
or years. When these infections remain untreated or are suboptimally
treated, patent parasitemic episodes punctuate relatively long periods
in which no parasites can be demonstrated microscopically. Throughout
the course of the infection, parasites are destroyed mainly by immune
mechanisms or drug treatment. Damaged or dying parasites also arise
when merozoites fail to reinvade or if the physiological environment of
the host is unsuitable for parasite development (e.g., in the presence
of fever, nutritional deficiencies, or hemoglobinopathies). The removal
of these parasites is undertaken primarily by circulating phagocytic
cells and spleen macrophages. The abilities of parasite-specific PCR
assays to detect low-grade parasitemias and to characterize the
composition of the parasite populations are being increasingly
exploited in diverse epidemiological studies. In addition to providing
accurate prevalence data (4, 23, 27, 28), important insights
into the biology of P. falciparum are derived from the PCR
analysis of parasite dynamics (9, 12), morbidity
associations (8, 11, 19), transmission (2, 20,
22), and the emergence of drug resistance (1, 10, 15, 26,
35). The role of PCR detection and analysis in the evaluation of
vaccine trials is now recognized and is likely to expand in the future
(6, 30). The possibility that any of the results obtained
from PCR analysis might be due to parasite DNA lingering in the
circulation long after the parasites have been eliminated has often
been raised. If this were often the case, some conclusions derived from
amplification data would have to be revised. Experimental infections of
mice were used to address this issue through the analysis of peripheral
blood obtained following clearance of very high parasite burdens
(rarely seen in human infections) either by chemotherapy or through
immune mechanisms. Parasites in individual blood samples were detected
by using a sensitive nested PCR assay, and their viability was
determined by subinoculation. It was found that parasite material is
cleared very quickly from the circulation and that the PCR signal is
associated mainly with the presence of viable parasites. In a few
samples, the PCR and subinoculation results were not in agreement.
Twenty-four hours following injection of freeze-thawed parasite
material, PCR amplification was positive but subinoculation was not
(Fig. 1A); thus, full clearance of the DNA present in this material from the circulation requires more than 24 h but less than 48 h. In the drug clearance experiment, the PCR assay was positive on days
13 to 16 while subinoculation proved negative (Fig. 1B). The prolonged
detection of parasites by PCR alone, observed only in the drug
clearance experiment, might be due to the presence of live but
drug-damaged parasites, which would be unable to initiate an infection
in a reporter mouse. This is supported by the microscopic detection of
a single parasite once in a reporter mouse (inoculated with day 15 blood, Fig. 1B), which did not develop an infection. Another possible
explanation rests with the exquisite sensitivity of both methods of
parasite detection; thus, when only one or two parasites are present in
a sample, there is a probability that one of the aliquots analyzed
would not contain any parasites. This all-or-none effect has been
previously noted in the PCR detection of parasites (29).
Indeed, a negative PCR amplification and a positive subinoculation
result were obtained with one sample from the immune clearance
experiment (data not shown). These few cases, however, occurred only
with samples obtained soon after the last sample found to be positive
by both methods.
In malaria, parasites are removed by circulating and
reticuloendothelial phagocytes (31). In the present
experiments, large numbers of parasites were eliminated by drug
treatment or immunity. Nonetheless, positive PCR amplification was
associated with the presence of viable parasites. Thus, either parasite
nuclear material is degraded rapidly after phagocytosis, or the loaded
phagocytic cells are not found in the peripheral circulation.
Although the experiments were necessarily performed with mice, since
human experimentation is ethically excluded, the conclusion drawn
should be equally applicable to the clearance of parasites in human
infections. Some indirect evidence derived from the PCR analysis of
P. falciparum populations in longitudinal blood samples supports this view. Genetically different populations are often seen in
the circulation on consecutive days or for only part of the sampling
period, in both untreated and treated infections (12, 15).
The fact that a particular parasite line is no longer detectable by PCR
analysis of peripheral blood following natural clearance or clearance
through drug treatment implies that material from this line is quickly
removed from the circulation. In a separate study, it was also found
that DNA from asexual parasites is also removed within 48 h after
ingestion by anopheline mosquitoes, as determined by nested PCR
amplification (21).
We therefore conclude that specific amplification of parasite sequences
from blood samples accurately reflects the presence of viable or very
recently killed or damaged parasites. These results add further
confidence to information obtained by PCR analysis of malaria
parasites. It remains to be established whether these conclusions are
applicable to other diseases caused by blood-dwelling parasites, such
as leishmaniasis, trypanosomiasis, and filariasis.
 |
ACKNOWLEDGMENT |
We thank K. Neil Brown for support, highly valuable comments and
suggestions, and reviewing the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Infection and Tropical Medicine, Imperial College School of Medicine, Lister Unit, Northwick Park Hospital, Harrow, Middlesex HA1 3UJ, United
Kingdom. Phone: (44) (181) 869 3507. Fax: (44) (181) 869 3504. E-mail: g.snounou{at}ic.ac.uk.
Editor: S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Babiker, H.,
L. Ranford-Cartwright,
A. Sultan,
G. Satti, and D. Walliker.
1994.
Genetic evidence that RI chloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasites.
Trans. R. Soc. Trop. Med. Hyg.
88:328-331[Medline].
|
| 2.
|
Babiker, H. A.,
L. C. Ranford-Cartwright,
D. Currie,
J. D. Charlwood,
P. Billingsley,
T. Teuscher, and D. Walliker.
1994.
Random mating in a natural population of the malaria parasite Plasmodium falciparum.
Parasitology
109:413-421.
|
| 3.
|
Barker, R. H. J.,
T. Banchongaksorn,
J. M. Courval,
W. Suwonkerd,
K. Rimwungtragoon, and D. F. Wirth.
1992.
A simple method to detect Plasmodium falciparum directly from blood samples using the polymerase chain reaction.
Am. J. Trop. Med. Hyg.
46:416-426.
|
| 4.
|
Bottius, E.,
A. Guanzirolli,
J.-F. Trape,
C. Rogier,
L. Konate, and P. Druilhe.
1996.
Malaria: even more chronic in nature than previously thought; evidence for subpatent parasitaemia detectable by the polymerase chain reaction.
Trans. R. Soc. Trop. Med. Hyg.
90:15-19[Medline].
|
| 5.
|
Brown, K. N.,
W. Jarra, and L. A. Hills.
1976.
T cells and protective immunity to Plasmodium berghei in rats.
Infect. Immun.
14:858-871[Abstract/Free Full Text].
|
| 6.
|
Cheng, Q.,
G. Lawrence,
C. Reed,
A. Stowers,
L. Ranford-Cartwright,
A. Creasy,
R. Carter, and A. Saul.
1997.
Measurement of Plasmodium falciparum growth rates in vivo: a test for malaria vaccine.
Am. J. Trop. Med. Hyg.
57:495-500.
|
| 7.
|
Contamin, H.,
T. Fandeur,
S. Bonnefoy,
F. Skouri,
F. Ntoumi, and O. Mercereau-Puijalon.
1995.
PCR typing of field isolates of Plasmodium falciparum.
J. Clin. Microbiol.
33:944-951[Abstract].
|
| 8.
|
Contamin, H.,
T. Fandeur,
C. Rogier,
S. Bonnefoy,
L. Konate,
J.-F. Trape, and O. Mercereau-Puijalon.
1996.
Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children.
Am. J. Trop. Med. Hyg.
54:632-643.
|
| 9.
|
Daubersies, P.,
S. Sallenave-Sales,
S. Magne,
J.-F. Trape,
H. Contamin,
T. Fandeur,
C. Rogier,
O. Mercereau-Puijalon, and P. Druilhe.
1996.
Rapid turnover of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area.
Am. J. Trop. Med. Hyg.
54:18-26.
|
| 10.
|
Duraisingh, M. T.,
C. J. Drakeley,
O. Muller,
R. Bailey,
G. Snounou,
G. A. T. Targett,
B. M. Greenwood, and D. C. Warhurst.
1997.
Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine.
Parasitology
114:205-211.
|
| 11.
|
Engelbrecht, F.,
I. Felger,
B. Genton,
M. Alpers, and H.-P. Beck.
1995.
Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes.
Exp. Parasitol.
81:90-96[Medline].
|
| 12.
|
Färnert, A.,
G. Snounou,
R. Ingegerd, and A. Björkman.
1997.
Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area.
Am. J. Trop. Med. Hyg.
56:538-547.
|
| 13.
|
Felger, I.,
L. Tavul, and H.-P. Beck.
1993.
Plasmodium falciparum: a rapid technique for genotyping the merozoite surface protein 2.
Exp. Parasitol.
77:372-375[Medline].
|
| 14.
|
Hulier, E.,
P. Pétour,
G. Snounou,
M.-P. Nivez,
F. Miltgen,
D. Mazier, and L. Rénia.
1996.
A method for the quantitative assessment of malaria parasite development in organs of the mammalian host.
Mol. Biochem. Parasitol.
77:127-135[Medline].
|
| 15.
| Irion, A., I. Felger, S. Abdullah, T. Smith, R. Mull, M. Tanner, C. Hatz, and H.-P. Beck. Distinction of
recrudescences from new infections by PCR-RFLP analysis in comparative
trial of CGP56697 and chloroquine in Tanzanian children. Trop. Med.
Int. Health, in press.
|
| 16.
|
Jarra, W., and K. N. Brown.
1985.
Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness of inter- and intra-species specificity of immunity induced by infection.
Parasite Immunol.
7:595-606[Medline].
|
| 17.
|
Jaureguiberry, G.,
I. Hatin,
L. D. Auriol, and G. Galibert.
1990.
PCR detection of Plasmodium falciparum by oligonucleotide probes.
Mol. Cell. Probes
4:409-414[Medline].
|
| 18.
|
Kain, K. C., and D. E. Lanar.
1991.
Determination of genetic variation within Plasmodium falciparum by enzymatically amplified DNA from filter paper disks impregnated with whole blood.
J. Clin. Microbiol.
29:1171-1174[Abstract/Free Full Text].
|
| 19.
|
Ntoumi, F.,
O. Mercereau-Puijalon,
S. Ossari,
A. Luty,
J. Reltien,
A. Georges, and P. Millet.
1997.
Plasmodium falciparum: sickle-cell trait is associated with higher prevalence of multiple infections in Gabonese children with asymptomatic infections.
Exp. Parasitol.
87:39-46[Medline].
|
| 20.
|
Paul, R. E. L.,
M. J. Packer,
M. Walmsley,
M. Lagog,
L. C. Ranford-Cartwright,
R. Paru, and K. P. Day.
1995.
Mating patterns in malaria parasite populations of Papua New Guinea.
Science
269:1709-1711[Abstract/Free Full Text].
|
| 21.
|
Pinto, J.,
A. P. Arez,
S. Franco,
V. E. de Rosario,
K. Palsson,
T. G. T. Jaenson, and G. Snounou.
1997.
Simplified methodology for PCR investigation of midguts from mosquitoes of the Anopheles gambiae complex, in which the vector and Plasmodium species can both be identified.
Ann. Trop. Med. Parasitol.
91:217-219[Medline].
|
| 22.
|
Ranford-Cartwright, L. C.,
P. Balfe,
R. Carter, and D. Walliker.
1993.
Frequency of cross-fertilization in the human malaria parasite Plasmodium falciparum.
Parasitology
107:11-18.
|
| 23.
|
Roper, C.,
I. M. Elhassan,
L. Hviid,
H. Giha,
W. Richardson,
H. Babiker,
G. M. H. Satti,
T. G. Theander, and D. E. Arnot.
1996.
Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan.
Am. J. Trop. Med. Hyg.
54:325-331.
|
| 24.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 25.
|
Snewin, V. A.,
M. Herrera,
G. Sanchez,
A. Scherf,
G. Langsley, and S. Herrera.
1991.
Polymorphism of the alleles of the merozoite surface antigens MSA1 and MSA2 in Plasmodium falciparum wild isolates from Colombia.
Mol. Biochem. Parasitol.
49:265-275[Medline].
|
| 26.
| Snounou, G., and H.-P. Beck. The use of
PCR-genotyping in the assessment of recrudescence or reinfection after
antimalarial drug treatment. Parasitol. Today, in press.
|
| 27.
|
Snounou, G.,
L. Pinheiro,
A. Gonçalves,
L. Fonseca,
F. Dias,
K. N. Brown, and V. E. de Rosario.
1993.
The importance of sensitive detection of malaria parasites in the human and mosquito hosts in epidemiological studies, as shown by the analysis of field samples from Guinea Bissau.
Trans. R. Soc. Trop. Med. Hyg.
87:649-653[Medline].
|
| 28.
|
Snounou, G.,
S. Viriyakosol,
W. Jarra,
S. Thaithong, and K. N. Brown.
1993.
Identification of the four human malaria species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections.
Mol. Biochem. Parasitol.
58:283-292[Medline].
|
| 29.
|
Snounou, G.,
S. Viriyakosol,
X. P. Zhu,
W. Jarra,
L. Pinheiro,
V. E. de Rosario,
S. Thaithong, and K. N. Brown.
1993.
High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction.
Mol. Biochem. Parasitol.
61:315-320[Medline].
|
| 30.
|
Stoute, J. A.,
M. Slaoui,
D. G. Heppner,
P. Momin,
K. E. Kester,
P. Desmons,
B. T. Wellde,
N. Garçon,
U. Krzych,
M. Marchand,
W. R. Ballou, and J. D. Cohen.
1997.
A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria.
N. Engl. J. Med.
336:86-91[Abstract/Free Full Text].
|
| 31.
|
Talliaferro, W. H.
1949.
Immunity to malaria infections, p. 935-965.
In
M. F. Boyd (ed.), Malariology. A comprehensive survey of all aspects of this group of diseases from a global standpoint, vol. II. The W. B. Saunders Co., Philadelphia, Pa.
|
| 32.
|
Tirasophon, W.,
M. Ponglikitmongkol,
P. Wilairat,
V. Boonsaeng, and S. Panyim.
1991.
A novel detection of a single Plasmodium falciparum in infected blood.
Biochem. Biophys. Res. Commun.
175:179-184[Medline].
|
| 33.
|
Tirasophon, W.,
P. Rajkulchai,
M. Ponglikitmongkol,
P. Wilairat,
V. Boonsaeng, and S. Panyim.
1994.
A highly sensitive, rapid, and simple polymerase chain reaction-based method to detect human malaria (Plasmodium falciparum and Plasmodium vivax) in blood samples.
Am. J. Trop. Med. Hyg.
51:308-313.
|
| 34.
|
Viriyakosol, S.,
N. Siripoon,
C. Petcharapirat,
P. Petcharapirat,
W. Jarra,
S. Thaithong,
K. N. Brown, and G. Snounou.
1995.
Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies.
Bull. W. H. O.
73:85-95[Medline].
|
| 35.
|
von Seidlein, L.,
S. Jaffar,
M. Pinder,
M. Haywood,
G. Snounou,
B. Gemperli,
I. Gathmann,
C. Royce, and B. Greenwood.
1997.
Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697.
J. Infect. Dis.
176:1113-1116[Medline].
|
| 36.
|
Wooden, J.,
E. E. Gould,
A. T. Paull, and C. H. Sibley.
1992.
Plasmodium falciparum: a simple polymerase chain reaction method for differentiating strains.
Exp. Parasitol.
75:207-212[Medline].
|
Infect Immun, August 1998, p. 3783-3787, Vol. 66, No. 8
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dal-Bianco, M. P., Koster, K. B., Kombila, U. D., Kun, J. F. J., Grobusch, M. P., Ngoma, G. M., Matsiegui, P. B., Supan, C., Ospina Salazar, C. L., Missinou, M. A., Issifou, S., Lell, B., Kremsner, P.
(2007). High Prevalence of Asymptomatic Plasmodium falciparum Infection in Gabonese Adults. Am J Trop Med Hyg
77: 939-942
[Abstract]
[Full Text]
-
KASEHAGEN, L. J., MUELLER, I., McNAMARA, D. T., BOCKARIE, M. J., KINIBORO, B., RARE, L., LORRY, K., KASTENS, W., REEDER, J. C., KAZURA, J. W., ZIMMERMAN, P. A.
(2006). Changing patterns of Plasmodium blood-stage infections in the wosera region of papua new Guinea monitored by light microscopy and high throughput PCR diagnosis.. Am J Trop Med Hyg
75: 588-596
[Abstract]
[Full Text]
-
Toure, F. S., Mezui-Me-Ndong, J., Ouwe-Missi-Oukem-Boyer, O., Ollomo, B., Mazier, D., Bisser, S.
(2006). Submicroscopic Plasmodium falciparum Infections Before and After Sulfadoxine-Pyrimethamine and Artesunate Association Treatment in Dienga, Southeastern Gabon.. Clin Med Res
4: 175-179
[Abstract]
[Full Text]
-
DEMBO, E. G., PHIRI, H. T., MONTGOMERY, J., MOLYNEUX, M. E., ROGERSON, S. J.
(2006). ARE PLASMODIUM FALCIPARUM PARASITES PRESENT IN PERIPHERAL BLOOD GENETICALLY THE SAME AS THOSE SEQUESTERED IN THE TISSUES?. Am J Trop Med Hyg
74: 730-732
[Abstract]
[Full Text]
-
Rougemont, M., Van Saanen, M., Sahli, R., Hinrikson, H. P., Bille, J., Jaton, K.
(2004). Detection of Four Plasmodium Species in Blood from Humans by 18S rRNA Gene Subunit-Based and Species-Specific Real-Time PCR Assays. J. Clin. Microbiol.
42: 5636-5643
[Abstract]
[Full Text]
-
Mockenhaupt, F. P., Ulmen, U., von Gaertner, C., Bedu-Addo, G., Bienzle, U.
(2002). Diagnosis of Placental Malaria. J. Clin. Microbiol.
40: 306-308
[Abstract]
[Full Text]
-
Mockenhaupt, F. P., May, J., Bergqvist, Y., Ademowo, O. G., Olumese, P. E., Falusi, A. G., Großterlinden, L., Meyer, C. G., Bienzle, U.
(2000). Concentrations of Chloroquine and Malaria Parasites in Blood in Nigerian Children. Antimicrob. Agents Chemother.
44: 835-839
[Abstract]
[Full Text]